NADPH-oxidase

亜型選択性的な製品

NADPH-oxidase製品

  • All (10)
  • NADPH-oxidase阻害剤 (10)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7171 Setanaxib (GKT137831) Setanaxib (GKT137831, GKT831) is a potent, dual NADPH oxidase NOX1/NOX4 inhibitor with Ki of 110 nM and 140 nM, respectively. Treatment with GKT137831 suppresses reactive oxygen species (ROS) production. GKT137831 partly inhibits ferroptosis.
Immunity, 2024, 57(1):52-67.e10
Nat Commun, 2024, 15(1):8663
MedComm (2020), 2024, 5(8):e668
S8639 DPI (Diphenyleneiodonium chloride) DPI (Diphenyleneiodonium chloride) is an inhibitor of NADPH oxidase and also a potent, irreversible, and time-, temperature-dependent iNOS/eNOS inhibitor. Diphenyleneiodonium chloride (DPI) also functions as a TRPA1 activator and selectively inhibits intracellular reactive oxygen species (ROS).
Cell Death Discov, 2024, 10(1):122
Int Immunopharmacol, 2024, 143(Pt 2):113504
J Exp Clin Cancer Res, 2023, 42(1):236
S6656 VAS2870 VAS2870 is a pan-NADPH oxidase (NOX) inhibitor.
J Nanobiotechnology, 2023, 21(1):117
Biomaterials, 2021, 271:120720
Clin Sci (Lond), 2020, 17;134(7):853-869
S8974 GSK2795039 GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.
Open Med (Wars), 2024, 19(1):20240898
Int J Mol Sci, 2023, 24(18)14369
Int J Mol Sci, 2023, 10.3390/ijms241814369
S0178 GLX351322 GLX351322 is a NADPH oxidase 4 (NOX4) inhibitor. GLX351322 inhibits hydrogen peroxide production from tetracycline inducible NOX4-overexpressing cells with IC50 of 5 μM.
Cell Commun Signal, 2024, 22(1):393.
Biomed Pharmacother, 2023, 165:115052
Oxid Med Cell Longev, 2023, 2023:1952348
S5304 2-Acetylphenothiazine (ML171) 2-Acetylphenothiazine (ML171, 2-APT) is a potent and selective inhibitor of NADPH-oxidase with IC50s of 0.25 μM, 5 μM, 3μM, 5 μM and 5.5 μM for NOX1, NOX2, NOX3, NOX4 and xanthine oxidase, respectively.
Front Plant Sci, 2024, 15:1418049
PLoS One, 2023, 18(5):e0285206
Cancers (Basel), 2022, 14(11)2643
S9617 G6PDi-1 G6PDi-1 is an effective inhibitor of glucose-6-phosphate dehydrogenase (G6PD). G6PDi-1 depletes NADPH and decreases inflammatory cytokine production.
EMBO J, 2023, e110620.
S0777 Isuzinaxib (APX-115 free base) APX-115 free base (Ewha-18278 free base) is a potent, orally active inhibitor of pan NADPH oxidase (pan-Nox) with Ki of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 free base (Ewha-18278 free base) significantly suppresses the expression of inflammatory molecules including MCP-1/CCL2, IL-6, and TNFα in the diabetic kidney.
S2425 Apocynin Apocynin is a selective NADPH-oxidase inhibitor with IC50 of 10 μM.
Antioxidants (Basel), 2023, 12(1)145
Antioxidants (Basel), 2023, 12(1)145
J Am Heart Assoc, 2023, 12(15):e029415
S2348 Rotenone Rotenone is a botanical insecticide that is an inhibitor of mitochondrial electron transport. Rotenone inhibits NADH/DB oxidoreductase and NADH oxidase with IC50 of 28.8 nM and 5.1 nM, respectively. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.
Cell Rep Med, 2024, 5(5):101519
Redox Biol, 2024, 70:103039
Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6):167249
S7171 Setanaxib (GKT137831) Setanaxib (GKT137831, GKT831) is a potent, dual NADPH oxidase NOX1/NOX4 inhibitor with Ki of 110 nM and 140 nM, respectively. Treatment with GKT137831 suppresses reactive oxygen species (ROS) production. GKT137831 partly inhibits ferroptosis.
Immunity, 2024, 57(1):52-67.e10
Nat Commun, 2024, 15(1):8663
MedComm (2020), 2024, 5(8):e668
S8639 DPI (Diphenyleneiodonium chloride) DPI (Diphenyleneiodonium chloride) is an inhibitor of NADPH oxidase and also a potent, irreversible, and time-, temperature-dependent iNOS/eNOS inhibitor. Diphenyleneiodonium chloride (DPI) also functions as a TRPA1 activator and selectively inhibits intracellular reactive oxygen species (ROS).
Cell Death Discov, 2024, 10(1):122
Int Immunopharmacol, 2024, 143(Pt 2):113504
J Exp Clin Cancer Res, 2023, 42(1):236
S6656 VAS2870 VAS2870 is a pan-NADPH oxidase (NOX) inhibitor.
J Nanobiotechnology, 2023, 21(1):117
Biomaterials, 2021, 271:120720
Clin Sci (Lond), 2020, 17;134(7):853-869
S8974 GSK2795039 GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) with pIC50 of 6.57 for NOX2-mediated activation of HRP/Amplex Red. GSK2795039 inhibits reactive oxygen species (ROS) production, NADPH consumption and reduces apoptosis.
Open Med (Wars), 2024, 19(1):20240898
Int J Mol Sci, 2023, 24(18)14369
Int J Mol Sci, 2023, 10.3390/ijms241814369
S0178 GLX351322 GLX351322 is a NADPH oxidase 4 (NOX4) inhibitor. GLX351322 inhibits hydrogen peroxide production from tetracycline inducible NOX4-overexpressing cells with IC50 of 5 μM.
Cell Commun Signal, 2024, 22(1):393.
Biomed Pharmacother, 2023, 165:115052
Oxid Med Cell Longev, 2023, 2023:1952348
S5304 2-Acetylphenothiazine (ML171) 2-Acetylphenothiazine (ML171, 2-APT) is a potent and selective inhibitor of NADPH-oxidase with IC50s of 0.25 μM, 5 μM, 3μM, 5 μM and 5.5 μM for NOX1, NOX2, NOX3, NOX4 and xanthine oxidase, respectively.
Front Plant Sci, 2024, 15:1418049
PLoS One, 2023, 18(5):e0285206
Cancers (Basel), 2022, 14(11)2643
S9617 G6PDi-1 G6PDi-1 is an effective inhibitor of glucose-6-phosphate dehydrogenase (G6PD). G6PDi-1 depletes NADPH and decreases inflammatory cytokine production.
EMBO J, 2023, e110620.
S0777 Isuzinaxib (APX-115 free base) APX-115 free base (Ewha-18278 free base) is a potent, orally active inhibitor of pan NADPH oxidase (pan-Nox) with Ki of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 free base (Ewha-18278 free base) significantly suppresses the expression of inflammatory molecules including MCP-1/CCL2, IL-6, and TNFα in the diabetic kidney.
S2425 Apocynin Apocynin is a selective NADPH-oxidase inhibitor with IC50 of 10 μM.
Antioxidants (Basel), 2023, 12(1)145
Antioxidants (Basel), 2023, 12(1)145
J Am Heart Assoc, 2023, 12(15):e029415
S2348 Rotenone Rotenone is a botanical insecticide that is an inhibitor of mitochondrial electron transport. Rotenone inhibits NADH/DB oxidoreductase and NADH oxidase with IC50 of 28.8 nM and 5.1 nM, respectively. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.
Cell Rep Med, 2024, 5(5):101519
Redox Biol, 2024, 70:103039
Biochim Biophys Acta Mol Basis Dis, 2024, 1870(6):167249

NADPH-oxidase阻害剤の選択性比較

Tags: NADPH-oxidase inhibitor|NADPH-oxidase agonist|NADPH-oxidase activator|NADPH-oxidase inducer|NADPH-oxidase antagonist|NADPH-oxidase signaling pathway|NADPH-oxidase assay kit